The findings demonstrate that integrin-mediated adhesion signaling can control and enhance IGF-1R activity through the CT Tyr1250/1251 phospho-site, thereby promoting a transformed and migratory phenotype in aggressive cancers. The gene discussed is IGF1R; the disease is cancer.